What Is Type 3 Diabetes? Insulin Resistance In The Brain That Could Trigger Alzheimer’s
Most people are aware of type 1 and type 2 diabetes, but did you know there is a type 3 diabetes as well! It is a more obscure term. Although it is not an accepted medical diagnosis, type 3 diabetes has been discussed in the literature as a possible relationship between insulin resistance in the brain and Alzheimer's disease. This link has been described to help explain how metabolic disorders impact brain health, causing cognitive decline and dementia.
Type 3 diabetes is more of a misnomer because it should not be confused with type 3c diabetes, which relates to pancreatic dysfunction. The term "type 3 diabetes," on the other hand, has been loosely used by some scientists to analogously propose that Alzheimer's disease is strongly implicated with insulin resistance in the brain.
This concept was conceptualized by Dr. Suzanne de la Monte and Dr. Jack Wands of Brown University in the year 2008. This hypothesis postulated that Alzheimer's disease may be called type 3 diabetes for it bears many similarities with glucose metabolism disorder type 2 diabetes. Their concept arises from the basic principle that insulin is fundamental to blood sugar regulation, but it is also the case with the brain. When brain cells become insulin-resistant, they lose access to glucose, impairing their function.
Research published in the Journal of Diabetes Science and Technology supports this hypothesis by indicating that insulin resistance can be a significant contributor to the occurrence of dementia, also referred to as Alzheimer's. The symptoms of memory loss and diminished reasoning are associated with impaired glucose metabolism in the body, especially in the cerebral tissue.
Although type 3 diabetes is not a "medical term," its symptoms correlate well with Alzheimer's diseases that are known to reduce the ability to think in an efficient manner and bring down brain health. These signs are:
- Loss of memory, especially short-term.
- Poor judgment and judgment ability
- Failure in recognizing people or places familiar once.
- Failure in the process of reading, writing or processing numbers
- Anxiety, agitation, or mood changes.
- Disorganized thoughts or confusion
- Lack of impulse control
As the disease advances, patients may be afflicted with severe complications including an inability to swallow or control their bodily functions. In the final stages, most patients die from fatal complications such as aspiration pneumonia.
This may not be well understood with regards to type 3 diabetes, or the exact link between insulin resistance and Alzheimer's disease. Some identified contributing factors include the following:
Insulin acts as an important regulatory mechanism of brain functions such as memory and cognition. The reduction in insulin signaling may impair metabolism of brain cells, thus bringing about neurodegeneration.
These diseases show a strong relationship and those individuals diagnosed with type 2 diabetes have double chances of getting Alzheimer's. In the two, the main causes can be chronic inflammation, oxidative stress, and a defect in glucose metabolism.
Insulin resistance associated with obesity, stress, and an unhealthy diet is considered a cause that may increase the chances of Alzheimer's disease.
Researches in Frontiers in Neuroscience and The Lancet Neurology have also highlighted that drugs used for antidiabetic medication may be crucial for the prevention or at least slowing down the course of Alzheimer's.
In 2022, in a study in Pharmaceuticals, researchers studied biomarker uptake in brain regions implicated in the faulty uptake and metabolism of blood sugar in Alzheimer’s patients.
Emerging Therapies
Research into such treatments as intranasal insulin has also been promising. Intranasal delivery of insulin directly to the brain has been reported to enhance glucose uptake by brain cells, improve memory, and boost cognitive performance. While such clinical trials have been shown to be successful, additional research is needed for safety and efficacy.
Medications
For patients being aggressive or agitated, antipsychotic drugs may be prescribed; however, therapies such as cognitive rehabilitation as well as cognitive stimulation therapy serve to preserve memory and executive function.
Lifestyle Interventions
Diet, exercise, and stress management are critical in preventing and managing insulin resistance. A review in the Journal of Alzheimer's Disease also highlighted the benefits of Kirtan Kriya meditation, which can regulate genes involved in insulin and glucose metabolism, improve sleep, and reduce inflammation.
Although type 3 diabetes is not officially recognized, its connection to Alzheimer’s disease underscores the importance of proactive measures for brain health. Some prevention strategies include:
1. Healthy Diet
Consuming a balanced diet rich in antioxidants, whole grains, and healthy fats may support brain health.
2. Regular Exercise
Physical activity improves insulin sensitivity, reduces inflammation, and enhances overall metabolic health.
3. Stress Reduction
Mindfulness practices, including meditation, have been shown to lower stress levels, which can reduce the risk of cognitive decline.
The term type 3 diabetes brings out the complex relationship between metabolic disorders and brain health. Even though it is not a recognized medical condition, the concept emphasizes the crucial role of insulin in brain function and its possible contribution to Alzheimer's disease. Continued research will hopefully provide hope for therapies such as intranasal insulin and lifestyle modifications.
Credits: Canva
As India steps into 2026, two familiar yet unsettling names have returned to the public health conversation. Nipah virus cases reported from West Bengal and fresh bird flu detections among crows in Bihar have raised questions about how dangerous these infections really are for humans. While both diseases originate in animals and can cross over to people, their risks, spread patterns and fatality levels are very different.
Nipah virus and avian influenza are both zoonotic, meaning they jump from animals to humans. Beyond that similarity, the comparison largely ends. Nipah is rare but extremely lethal when it infects humans. Bird flu, on the other hand, spreads widely among birds and poultry, but only occasionally infects people.
Health experts note that understanding this distinction is crucial. Nipah alarms public health systems because even a small cluster of cases can lead to severe illness and death. Bird flu triggers large scale surveillance mainly due to its impact on poultry and the economy, with human cases remaining uncommon.
Read: Bird Flu In India: How Safe Is It To Eat Chicken And Eggs?
The Nipah virus was first identified in Malaysia in the late 1990s and has since caused multiple outbreaks in South and Southeast Asia. Fruit bats are its natural carriers, and humans can get infected through contaminated food, contact with infected animals or close contact with an infected person.
Symptoms often begin like a common viral illness, with fever, headache and cough. In many patients, the disease progresses rapidly. Within days, some develop encephalitis, seizures, confusion and coma. Respiratory distress is also common in severe cases.
According to the World Health Organization, Nipah’s fatality rate ranges between 40 and 75 percent, depending on the outbreak and access to timely medical care. There is no approved vaccine or specific antiviral treatment. Doctors rely on intensive supportive care, which makes early detection and isolation critical.
In January 2026, West Bengal reported multiple Nipah cases, prompting contact tracing and monitoring of nearly 200 people. Most tested negative, and the WHO assessed the risk of wider spread as low. Still, the high death rate keeps Nipah firmly on India’s list of priority pathogens.
Bird flu, or avian influenza, is caused by influenza A viruses that primarily infect birds. Strains such as H5N1 and H9N2 have been detected repeatedly in India among poultry and wild birds. Bihar’s Darbhanga district recently reported thousands of bird deaths, triggering containment measures.
Humans usually get infected through close contact with sick or dead birds or contaminated environments. When infection does occur, symptoms can resemble seasonal flu at first, but severe cases may progress to pneumonia or acute respiratory distress.
Some bird flu strains have shown high fatality rates among confirmed human cases, sometimes close to 50 percent. However, experts stress that these numbers come from very small case counts. Sustained human to human transmission remains rare, which limits large outbreaks in people.
Read: Nipah Virus Outbreak In India: Myanmar Airport Tightens Health Screenings
In terms of individual risk, Nipah virus is considered deadlier for humans. Its consistently high fatality rate, lack of treatment options and potential to cause severe brain inflammation make it especially dangerous, even when case numbers are low.
Bird flu poses a broader threat to animal health and livelihoods, but its direct impact on human life has so far been limited. Public health officials continue to monitor both closely, knowing that vigilance, early reporting and strong surveillance are the best tools to prevent either virus from spiralling into a larger crisis.
Credits: Canva
After the death of 150 crows in Bihar's Bhagalpur district in Naugacha, sudden death of 1,500 crows in Chennai, in Tamil Nadu has again raised concerns over bird flu. At the center of all these is Highly Pathogen Avian Influenza or the HPAI, which is also known as bird flu or the A H5N1 virus. While the strain is known for being notorious and have jumped states, spreading outbreaks in many Indian states, including Jharkhand, Bihar, Maharashtra, Andhra Pradesh, Kerala, Telangana, and Tamil Nadu, the concerns do not end there. Many are concerned if it is a threat to humans too.
As per the World Health Organization (WHO) data, between January 2023 and December 2025, a total of 993 human cases of avian influenza were reported in 25 countries. Almost half of them, which is around 477 people, died. The virus has a fatality rate of 48 per cent.
Two different studies, one done by the universities of Cambridge and Glasgow that show how avian flu strains are multiplying even when the body temperatures could hinder viruses. Whereas, another important study led by Indian scientists, by Philip Cherian and Gautam Menon of Ashoka University, published in BMC Public Health predict if H5N1 or the bird flu virus, could start spreading among humans. How quickly must we act to stop it?
Human influenza viruses infect many each year. The seasonal strains we see most often fall under influenza A and tend to do well in the cooler temperatures of the upper respiratory tract, which is close to 33°C. They are less suited to the warmer, deeper parts of the lungs, where temperatures reach about 37°C.
As per Science Daily, when the body cannot slow an infection, the virus continues to multiply and spread, which can lead to more serious illness. Fever acts as a protective response, pushing body temperature as high as 41°C. Until now, the exact reason why fever slows some viruses but not others has been unclear.
Avian influenza behaves differently. These viruses usually grow in the lower respiratory tract, and in their natural hosts, such as ducks or seagulls, they often infect the gut. Temperatures in these areas can reach 40°C to 42°C, which helps explain their greater tolerance to heat.
Read: Could Bird Flu Become The Next Pandemic For Humans?
Using BharatSim, an open-source simulation platform originally developed during Covid-19, the researchers recreated what an outbreak might look like in real life. “The threat of an H5N1 pandemic in humans is a genuine one,” Prof Menon said, “but we can hope to forestall it through better surveillance and a more nimble public-health response.”
Their model begins where experts believe a real outbreak would: with a single human infection, most likely a poultry worker or someone exposed to infected birds at a farm or market. The danger, the researchers argue, lies not in that first case, but in whether sustained human-to-human transmission takes hold.
The study by Ashoka University has the most sobering findings in how fast control can slip away. According to the simulations, once cases rise beyond roughly two to ten people, the virus is likely to move beyond immediate contacts and into the wider community.
If households of close contacts are quarantined when just two cases are detected, the outbreak can almost certainly be contained. By the time ten cases are identified, however, the model suggests the infection has probably already spread far enough that early interventions no longer make a meaningful difference.
To ground their work in reality, the researchers focused on a village in Tamil Nadu’s Namakkal district, one of India’s largest poultry hubs. With more than 1,600 farms, around 70 million chickens and tens of millions of eggs produced daily, the region reflects the kind of dense human-animal interaction where spillovers are most likely.
In the simulation, the virus spreads outward from a single workplace into homes, schools and markets, tracking primary and secondary contacts. Once “tertiary” infections, contacts of contacts, appear, control becomes dramatically harder without severe measures such as lockdowns.
Read: Bird Flu Variant Can Now Withstand Fever, Sparking Stronger Human Threats
Culling birds work, but only if it happens before humans are infected. Once the spillover is done, isolating patients and quarantining is the only option that can stop the virus, that too if done very early. Targeted vaccination could help raise the threshold at which the virus can sustain itself. Quarantine imposed too early keeps families together longer, increasing household transmission. Imposed too late, it barely slows the outbreak at all.
Credits: Canva
What won't people do to get that gold. In the quest for so, Olympians re injecting hyaluronic acid in their penises. The reason? For skiing, it helps them fly better and further.
In January, a German newspaper, Bild reported that jumpers were injecting, what now is dubbed as Penisgate in their penis. The newspaper claimed that athletes inject the acid in the penis before they are measured for their suits.
Hyaluronic acid is used for cosmetic surgery, especially as a filler. Surgeons have also used it for penile girth enlargement. This is exactly why it is being used by the Olympians.
Injecting hyaluronic acid will increase the penile girth. However, experts point out that this means, one has to insert a lot of it in the penis to have this worked out. It is not a permanent solution, and can only last up to six to 12 months, depending on the absorption.
Inserting this will increase the penile girth or the penis circumference by one or two centimeters. As per the International Ski and Snowboard Federation, FIS, the surface area of their suits during competition could be increased by this, which increases their flight in the air, reported BBC.
"Every extra centimetre on a suit counts. If you suit has a 5% bigger surface area, you fly further," said FIS ski jumping's men race director Sandro Pertile, reported by BBC.
Ahead of each season, ski jumpers undergo measurements using 3D body scanners and are required to wear only elastic, body-tight underwear during the process.
Regulations allow suit measurements a tolerance of just 2–4 cm. As part of this assessment, athletes’ crotch height is also recorded. The suit’s crotch height must match the athlete’s own measurement, with an additional 3 cm permitted for men.
Hyaluronic acid injections into the penis can last for up to 18 months.
Athletes have previously faced scrutiny for attempting to boost performance through alterations or manipulation of their suits.
Experts caution that penile injections using hyaluronic acid can pose serious short- and long-term risks.
They warn that improper technique or incorrect dosing may lead to pain, disfigurement, deformity, infection, inflammation, altered sensation, and sexual dysfunction. In rare cases, infections can worsen, causing tissue death (gangrene) and even loss of the penis.
© 2024 Bennett, Coleman & Company Limited